NCT03334617 2025-10-27
HUDSON
AstraZeneca
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT02664935 2025-05-21
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
University of Birmingham
Phase 2 Active not recruiting
NCT02117167 2024-01-10
SAFIR02_Lung
UNICANCER
Phase 2 Completed
NCT03366103 2023-10-17
Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT03106155 2018-09-20
[SUKSES-D]
Samsung Medical Center
Phase 2 Terminated